Evidence and Innovation into Clinical Care

Evidence and Innovation into Clinical Care: Health Services Research Symposium

7 November 2018 9:30am1:30pm
This Joint AusHSI-CBEH symposium will present research evidence on inefficiency in the use of health care resources in the form of low value care and opportunities for improving efficiency through improvements in resource use.

Innovation speed in the pharmaceutical industry

16 October 2018 11:00am12:00pm
This talk discusses emerging research on the factors contributing to greater innovation speed in the pharmaceutical industry, with a particular focus on novel drugs and precision medicines, their regulation, and the contribution of both inter-organisational alliances and public-private partnerships.

Value of Information Analysis Informing Adoption and Research Decisions in Health Care Interventions

14 August 2018 11:30am12:30pm
The presentation will be given by Dr Haitham Tuffaha, Griffith University.
Adam Oliver

Your Money and Your Life: Risk Attitudes over Gains and Losses

6 August 2018 11:00am12:00pm
Adam Oliver is an Associate Professor at the London School of Economics with interest in health from a behavioural economic and public policy perspective.

Nudging our way to more efficient health care: Unleashing the potential of behavioural economics

9 July 2018 8:30am5:30pm
Healthcare managers, planners and policymakers are invited to hear from global leaders in behavioural economics in health including Associate Professor Adam Oliver from the London School of Economics and Political Science.
newborn baby

Prenatal economics shocks and birth outcomes

11 June 2018 12:00pm1:00pm
The effects of major prenatal economic shocks experienced by mothers on two indicators of newborn infant health - birth weights and head circumferences.
Introduction to Health Economics & Evaluation Workshop

Introduction to Health Economics & Evaluation Workshop

3 November 2017 9:00am3:45pm
At this one-day workshop, you’ll learn how economic investment proposals (like grants and business cases) are commonly appraised, and what evaluation panels will be looking for in the data and descriptions you present to them.
Economic evaluation in ageing research: From treatment to intervention

Economic evaluation in ageing research: From treatment to intervention

28 September 2017 11:00am1:00pm
The ageing population is one of the major global health challenges. In ageing research, economic evaluation studies would provide information about the cost-effectiveness of medical treatments, health technologies or interventions and thus contribute to guiding healthcare resource allocation and forming health policies.
UQ Alumni Reception in Singapore

UQ Alumni Reception in Singapore

7 September 2017 7:00pm9:00pm
This event is a wonderful opportunity to meet fellow UQ alumni in your area, and to hear Professor Connelly's insights on the topic 'Is healthcare a luxury? What drives health expenditure?'.
Professor Anthony Scott

Physician competition and low value health care. Evidence from primary care.

29 August 2017 2:00pm3:00pm
This seminar discusses a paper examining the impact of competition on the quality of care provided by physicians.
Dr Erez Yoeli

Behavioural insights promote Tuberculosis treatment success in a randomized control trial

9 August 2017 1:30pm2:30pm
Successful Tuberculosis (TB) treatment is critical for reducing transmission and lowering treatment costs. Mobile health interventions incorporating behavioural insights promise to increase treatment success, but have largely fallen short of expectations.
Guest speaker Dr Erez Yoeli.
Queensland Brain Institute Neuroscience Seminars

Connecting health economics and brain research

26 April 2017 11:00am12:00pm
Professor Brenda Gannon
Mater Research Institute Chair in Health Economics, Centre for Business and Economics of Health, University of Queensland
Is health care a luxury? What drives health expenditure?

Global Leadership Series: Is healthcare a luxury? What drives health expenditure?

23 February 2017 6:00pm8:00pm
Australia’s ageing population presents major challenges to the health sector however it is not the main source of health expenditure growth.